Cells,
Journal Year:
2022,
Volume and Issue:
12(1), P. 12 - 12
Published: Dec. 20, 2022
The
SARS-CoV-2
infection
was
previously
associated
with
the
expression
of
dopamine
biosynthetic
enzyme
L-Dopa
decarboxylase
(DDC).
Specifically,
a
negative
correlation
detected
between
DDC
mRNA
and
RNA
levels
in
vitro
infected
epithelial
cells
nasopharyngeal
tissue
COVID-19
patients
mild/no
symptoms.
However,
DDC,
among
other
genes
related
to
both
SARS-CoV-2-infection
(ACE2,
dACE2,
EPO),
upregulated
these
patients,
possibly
attributed
an
orchestrated
host
antiviral
response.
Herein,
by
comparing
swab
samples
severe/critical
mild
cases,
we
showed
20
mean-fold
reduction,
highlighting
importance
this
gene
as
potential
marker
severity.
Moreover,
identified
association
key
catecholamine
biosynthesis/metabolism-related
genes,
whole
blood
from
hospitalized
cultured
cells.
viral
downregulated
part
pathway
(reduction
up
7.5
mean-fold),
while
enhanced
catabolizing
(increase
monoamine
oxidases
A
B
15
10
mean-fold,
respectively)
vivo,
irrespectively
presence
comorbidities.
In
accordance,
sera
severe
cases
were
reduced
(up
3.8
mean-fold).
Additionally,
moderate
positive
MAOA
(r
=
0.527,
p
<
00001)
upon
SARS-CoV-2-infection.
These
observations
consistent
data
SARS-CoV-2-infected
Vero
E6
A549
Furthermore,
or
treatment
attenuated
virus-derived
cytopathic
effect
55%
59%,
respectively.
mediated
suppression
biosynthesis
cell
culture
was,
at
least
part,
hypoxia-like
conditions
triggered
infection.
findings
suggest
that
L-Dopa/dopamine
intake
may
have
preventive
therapeutic
value
for
patients.
Clinical Epigenetics,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Aug. 20, 2024
The
epigenetic
status
of
patients
6-month
post-COVID-19
infection
remains
largely
unexplored.
existence
long-COVID,
or
post-acute
sequelae
SARS-CoV-2
(PASC),
suggests
potential
long-term
changes.
Long-COVID
includes
symptoms
like
fatigue,
neurological
issues,
and
organ-related
problems,
regardless
initial
severity.
mechanisms
behind
long-COVID
are
unclear,
but
virus-induced
changes
could
play
a
role.
Our
study
explores
the
lasting
impacts
infection.
We
analyzed
genome-wide
DNA
methylation
patterns
in
an
Italian
cohort
96
6
months
after
COVID-19
exposure,
comparing
them
to
191
healthy
controls.
identified
42
CpG
sites
with
significant
differences
(FDR
<
0.05),
primarily
within
islands
gene
promoters.
Dysregulated
genes
highlighted
links
glutamate/glutamine
metabolism,
which
may
be
relevant
PASC
symptoms.
Key
significance
effects
include
GLUD1,
ATP1A3,
ARRB2.
Furthermore,
Horvath's
clock
showed
slight
age
acceleration
patients.
also
observed
substantial
increase
stochastic
mutations
(SEMs)
group,
implying
drift.
SEM
analysis
790
affected
genes,
indicating
dysregulation
pathways
related
insulin
resistance,
VEGF
signaling,
apoptosis,
hypoxia
response,
T-cell
activation,
endothelin
signaling.
provides
valuable
insights
into
consequences
COVID-19.
Results
suggest
possible
associations
accelerated
aging,
drift,
disruption
critical
biological
linked
immune
vascular
health.
Understanding
these
crucial
for
elucidating
complex
developing
targeted
therapeutic
interventions.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(12), P. 2526 - 2526
Published: Dec. 7, 2024
Viral
respiratory
infections
(VRIs)
are
a
leading
cause
of
morbidity
and
mortality
worldwide,
making
them
significant
public
health
concern.
During
infection,
viruses,
including
Influenza
virus,
SARS-CoV-2,
syncytial
virus
(RSV),
trigger
an
antiviral
immune
response,
specifically
boosting
the
inflammatory
response
that
plays
critical
role
in
their
pathogenesis.
The
induced
by
viruses
can
be
double-edged
sword
since
it
initially
to
protective/reparative
from
virus-induced
injuries.
Still,
also
detrimental
host
cells
tissues.
However,
mechanisms
differentiate
complex
crosstalk
between
favorable
responses
harmful
poorly
understood.
This
review
explores
interplay
viral
pathogens
mainly
focusing
on
inflammation
pathogenesis
VRIs.
We
discuss
how
both
contain
exacerbate
progression
infections,
highlighting
potential
therapeutic
targets
emerging
drugs
for
modulating
aberrant
during
Pharmacological Reports,
Journal Year:
2022,
Volume and Issue:
74(6), P. 1149 - 1165
Published: Aug. 23, 2022
Abstract
The
unprecedented
pandemic
of
SARS-CoV-2
(severe
acute
respiratory
syndrome
coronavirus
2),
which
leads
to
COVID-19,
is
threatening
global
health.
Over
the
last
2
years,
we
have
witnessed
rapid
progress
in
research
focusing
on
developing
new
antiviral
vaccines
and
drugs,
as
well
academic
clinical
efforts
understand
biology
pathology
COVID-19.
roles
proteases
among
master
regulators
invasion
replication
their
pivotal
host
defence
against
this
pathogen,
including
programmed
cell
death,
not
been
established.
Our
understanding
protease
function
health
disease
has
increased
considerably
over
two
decades,
with
caspases,
matrix
metalloproteases,
transmembrane
serine
representing
most
prominent
examples.
Therefore,
during
COVID-19
pandemic,
these
enzymes
investigated
potential
molecular
targets
for
therapeutic
interventions.
Proteases
that
are
responsible
entry
replication,
such
TMPRSS2,
ACE2
or
cathepsins,
screened
inhibitor
libraries
discover
lead
structures
further
drug
design
would
prevent
virus
multiplication.
On
other
hand,
orchestrate
death
can
also
be
harnessed
enhance
desired
demise
infected
cells
through
apoptosis
attenuate
highly
inflammatory
lytic
undesired
cytokine
storms,
a
major
hallmark
severe
Given
role
SARS-CoV-2-induced
discuss
individual
catalytic
interactions
article.
We
provide
rationale
targeting
participating
treatments
identify
knowledge
gaps
might
better
mechanism
underlying
death.
Frontiers in Bioscience-Landmark,
Journal Year:
2022,
Volume and Issue:
27(11), P. 316 - 316
Published: Nov. 30, 2022
Background:
The
recently
emerged
variants
of
the
severe
acute
respiratory
coronavirus
2
(SARS-CoV-2)
pose
a
threat
to
public
health.
Understanding
pathogenicity
these
is
salient
factor
in
development
effective
SARS-CoV-2
therapeutics.
This
study
aimed
compare
expression
patterns
genes
involved
immune
responses
K18-hACE2
mice
infected
with
wild-type,
Delta,
and
Omicron
variants.
Methods:
were
intranasally
either
wild-type
(B.1),
Delta
(B.1.617.2),
or
(B.1.1.529)
On
day
6
post-infection,
lung,
brain,
kidney
tissues
collected
from
each
variant-infected
group.
mRNA
levels
39
response
all
three
groups
compared
by
RT-qPCR.
Viral
titers
measured
using
median
tissue
culture
infectious
dose
(TCID50)
assay
expressed
as
Log10
TCID50/0.1
g.
statistical
significance
differences
gene
was
determined
one-way
analysis
variance
(ANOVA)
(alpha
=
0.05).
Results:
toll-like
receptors
(TLRs)
upregulated
lung
brain
wild-type-
Delta-infected
but
not
those
Omicron-infected
highest
cytokines,
including
interleukin
(IL)-1α,
IL-1β,
IL-17α,
interferon,
tumor
necrosis
factors,
observed
lungs
variant.
Additionally,
CCL4,
CCL11,
CXCL9,
CXCL10
(>3-fold)
wild-type-infected
mice,
markedly
higher
expressions
than
lungs.
Most
apoptotic
factors
mainly
(caspase
8,
caspase
9,
p53,
Bax,
Bak,
BCL-2,
Bcl-XL),
whereas
neither
nor
showed
more
3-fold
upregulation
factors.
Conclusions:
Collectively,
our
findings
revealed
that
variant
exhibited
pathogenicity,
followed
variant,
then
Cells,
Journal Year:
2022,
Volume and Issue:
12(1), P. 12 - 12
Published: Dec. 20, 2022
The
SARS-CoV-2
infection
was
previously
associated
with
the
expression
of
dopamine
biosynthetic
enzyme
L-Dopa
decarboxylase
(DDC).
Specifically,
a
negative
correlation
detected
between
DDC
mRNA
and
RNA
levels
in
vitro
infected
epithelial
cells
nasopharyngeal
tissue
COVID-19
patients
mild/no
symptoms.
However,
DDC,
among
other
genes
related
to
both
SARS-CoV-2-infection
(ACE2,
dACE2,
EPO),
upregulated
these
patients,
possibly
attributed
an
orchestrated
host
antiviral
response.
Herein,
by
comparing
swab
samples
severe/critical
mild
cases,
we
showed
20
mean-fold
reduction,
highlighting
importance
this
gene
as
potential
marker
severity.
Moreover,
identified
association
key
catecholamine
biosynthesis/metabolism-related
genes,
whole
blood
from
hospitalized
cultured
cells.
viral
downregulated
part
pathway
(reduction
up
7.5
mean-fold),
while
enhanced
catabolizing
(increase
monoamine
oxidases
A
B
15
10
mean-fold,
respectively)
vivo,
irrespectively
presence
comorbidities.
In
accordance,
sera
severe
cases
were
reduced
(up
3.8
mean-fold).
Additionally,
moderate
positive
MAOA
(r
=
0.527,
p
<
00001)
upon
SARS-CoV-2-infection.
These
observations
consistent
data
SARS-CoV-2-infected
Vero
E6
A549
Furthermore,
or
treatment
attenuated
virus-derived
cytopathic
effect
55%
59%,
respectively.
mediated
suppression
biosynthesis
cell
culture
was,
at
least
part,
hypoxia-like
conditions
triggered
infection.
findings
suggest
that
L-Dopa/dopamine
intake
may
have
preventive
therapeutic
value
for
patients.